Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Millions	Apr. 30, 2024	Oct. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 2,517	$ 3,232
Accounts receivable, net of allowance for credit losses of $84 and $93, respectively	4,319	4,237
Inventory	7,512	6,862
Other current assets	4,245	3,646
Total current assets	18,593	17,977
Property, plant and equipment, net	2,794	2,827
Goodwill	8,590	8,591
Other non-current assets	7,456	7,609
Total assets	37,433	37,004
Current liabilities:
Notes payable and short-term borrowings	265	230
Accounts payable	14,362	14,046
Other current liabilities	10,212	10,212
Total current liabilities	24,839	24,488
Long-term debt	9,327	9,254
Other non-current liabilities	4,183	4,331
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 978 and 989 shares issued and outstanding at April 30, 2024 and October 31, 2023, respectively)	10	10
Additional paid-in capital	1,663	1,505
Accumulated deficit	(2,257)	(2,361)
Accumulated other comprehensive loss	(332)	(223)
Total stockholders’ deficit	(916)	(1,069)
Total liabilities and stockholders’ deficit	$ 37,433	$ 37,004